EMILY ALLISS: Open Payments
NPI 1982328530 · PHILADELPHIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$905 in 24 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $1,890 · 2025 $905
Food & beverage: $905
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. | 12 | $519 |
| Edwards Lifesciences Corporation | 1 | $166 |
| Amgen Inc. | 3 | $70 |
| Novartis Pharmaceuticals Corporation | 4 | $62 |
| HEARTFLOW, INC. | 2 | $51 |
| Novo Nordisk Inc | 1 | $23 |
| AstraZeneca Pharmaceuticals LP | 1 | $14 |
Products named: SYMPLICITY G3, SAPIEN 3 Ultra RESILIA, REPATHA, LEQVIO, FFRct, Wegovy, FARXIGA.
Industry payments across PA — which companies pay providers there.
